Searched for
ERIS
Ipca Laboratories among 5 stocks showing bullish RSI upswingFive Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish moment...- JSW Dulux among 4 stocks flashing bullish signals, hinting at a possible uptrendFour Nifty500 stocks appeared on the White Marubozu bullish scanner on May 29, signalling strong buying momentum across select counters. Th...
- Dividend alert! Last date to buy Bajaj Auto, GSK Pharma and 10 other stocks for solid payouts. Details hereTwelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...
- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
- Northern water snake size explained: Why this harmless snake can look massiveNorthern water snakes are common in eastern North America. These snakes are harmless and not venomous. Many people mistake them for dangero...
- Eris Lifesciences among 5 stocks showing bullish RSI upswingFive Nifty500 stocks featured in the RSI Trending Up scan on May 20 after gaining over 5%. The RSI moved above the 50 mark from lower level...
- Crorepati investors splurge $1 billion to buy these 10 stocks. Should you follow the smart money?Wealthy investors are making significant moves, pouring over $1 billion into ten select stocks. This concentrated buying occurs even as the...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Padma Doree textile debuts in New Delhi featuring 13 designersThe event highlighted the collaborative potential of India's diverse textile heritage, featuring artisans and designers from Madhya Pradesh...
- Dr. Reddy’s among 4 stocks showing bullish RSI upswingFour stocks from the Nifty500 universe that gained over 3% were identified using the RSI Trending Up scan on April 23. The signal occurs wh...
- Gainers & Losers: Nestle, Groww and Ola among 7 big movers on TuesdaySeven major stocks—including Nestle, Groww, Lemon Tree Hotels and Ola—logged sharp moves on Tuesday as markets rallied for a third straight...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Burdett ‘Burd’ Sisler, oldest living Canadian and WWII veteran with 14 great-great-grandchildren, dies weeks before celebrating his 111th birthdayBurdett ‘Burd’ Sisler dies at 110: Canada mourns Burdett 'Burd' Sisler, who passed away at 110, just weeks before his 111th birthday. A dec...
- Man jumps into historic Erie Canal to evade police pursuit and what happened next will shock you; chilling details insideA police chase came to a dramatic end when a man jumped into the Erie Canal while attempting to evade officers, with authorities now invest...
- Natco, Eris Life to launch slimming shots in both Vial and Pen formatsNatco Pharma and Eris Lifesciences are launching generic semaglutide weight-loss injections. The companies are introducing both vial and pe...
- Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in IndiaShares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco...
- Eris Lifesciences shares in focus on move to acquire Swiss Parenterals in Rs 423 crore dealEris Lifesciences is set to fully acquire its injectable unit, Swiss Parenterals. The deal involves a share swap valued at Rs 423.3 crore. ...
- Eris Lifesciences reports 41% year-on-year rise in net profit in Q1Eris Lifesciences reported a robust 41% YoY increase in net profit, reaching Rs 125 crore for the first quarter, driven by strong performan...
- Eris: Symptoms, Vaccines and all about the new dominant Covid variant which is leading to a fresh wave in the U.S and U.KThe Eris variant, or EG.5, a dominant Covid subvariant, has surged to prominence as the most prevalent subvariant in the United States and ...
Load More
